Does chemotherapy always mean losing my hair?

Chemotherapy in Istanbul

In short

Chemotherapy uses drugs to kill or slow the growth of rapidly dividing cells, given in cycles — a treatment day followed by a rest period, repeated over weeks or months depending on the protocol. Administration in Istanbul (day-clinic chair, premedication, monitoring, oncologist review) runs $1,200–2,800 per cycle as an illustrative placeholder — about 69% less than Germany's comparable administration cost. The drugs themselves are itemized separately per protocol in every quote. A free 72-hour tumor-board second opinion reviews whether chemotherapy, and which regimen, fits your case.

Drugs given in cycles to slow or kill rapidly dividing cells. Administration in Istanbul runs $1,200–2,800/cycle (illustrative placeholder; drugs itemized separately) — about 69% less than Germany. A free 72h second opinion reviews your regimen.

Cost per cycle

UPDATED Q3 2026PLACEHOLDER

Component

Istanbul

Germany typ.

Typical use

Administration, day clinic

$1,200–2,800

$6,500

per cycle, any regimen

Day-clinic chair, administration, premedication, monitoring labs, oncologist review. The drugs themselves are itemized per protocol (biosimilars offered where approved) — never bundled into a flat number. Ranges come from partner-hospital quotes, updated quarterly.

Get an exact quote for your case

Cost per cycle

Q3 2026

Administration

$1,200–2,800

Germany typ. $6,500 · placeholder

How it's given

[ [ chemotherapy day-clinic chair ] ]

[ [ day-clinic chair ] ]

Outpatient day-clinic infusion

Setting

outpatient day clinic, most regimens

Access

peripheral IV, or a port for longer courses

Session length

varies by protocol — typically a few hours

Monitoring

bloodwork before each cycle

Cycle interval

protocol-dependent, typically 2–4 weeks

Access

IV or port

Session

varies · hours

The exact drugs, doses, and cycle schedule are set by the protocol appropriate to your specific diagnosis and staging — the tumor board's role is confirming that protocol, not this page.

When it's typically used

Typically suitable

As the primary systemic treatment for many cancer types, alone or combined with surgery/radiotherapy

Neoadjuvant (before surgery), to shrink a tumor first

Adjuvant (after surgery), to reduce recurrence risk

For metastatic disease, to control growth and manage symptoms

Usually better served otherwise

Some biomarker-defined tumors where targeted therapy or immunotherapy is preferred first

Very early, surgically curable disease where systemic therapy isn't indicated at all

Whether chemotherapy is indicated — and which regimen — depends entirely on your diagnosis, staging, and biomarker results. The tumor board says so either way.

Typically suitable

Primary systemic treatment · neoadjuvant (before surgery) · adjuvant (after surgery) · metastatic disease control

Usually better served otherwise

Biomarker-defined tumors better suited to targeted therapy/immunotherapy · very early disease needing no systemic treatment

Send your reports. Get a plan — with reasons.

A named specialist's board answers in 72 hours, free.

Free second opinionGet my free second opinion

Fair questions about chemotherapy

No — hair loss depends on the specific drugs in your regimen, not chemotherapy as a category. Some regimens cause it, many don't. Your oncologist can tell you what to expect for your specific drugs before treatment starts.

Every cancer case is individual. Assessments do not replace in-person examination.Every cancer case is individual. Assessments are based on the reports you provide and do not replace in-person examination. Survival statistics are population-level data, not personal predictions.

Targeted & hormone therapy Immunotherapy Ten questions before chemotherapy Lung cancer systemic therapy

Verify at

Chemotherapy to Treat Cancer — National Cancer Institute (NCI)

Types of chemotherapy — MedlinePlus (U.S. National Library of Medicine)

Get my free second opinion